Global Skin Permeation Testing 麻豆原创 Growth (Status and Outlook) 2024-2030

Publication ID:

LPI06241089

Publication Date:

June 12, 2024

Pages:

127

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

Skin Permeation Testing is an experimental method used to evaluate the penetration and absorption ability of chemical substances (such as drugs, cosmetic ingredients, etc.) on human skin. This type of testing is commonly used in areas such as drug development, cosmetic safety assessment and formulation optimization.
In Skin Permeation Testing, the substance to be tested (such as a pharmaceutical preparation or cosmetic sample) is usually applied to the skin surface or skin model, and then the penetration of the substance into the skin is observed through different experimental conditions and methods. These tests can provide information on the substance's absorption rate on the skin, penetration depth, and distribution across skin layers, helping to evaluate its impact and safety on the human body.
The global Skin Permeation Testing market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
The 鈥淪kin Permeation Testing Industry Forecast鈥� looks at past sales and reviews total world Skin Permeation Testing sales in 2022, providing a comprehensive analysis by region and market sector of projected Skin Permeation Testing sales for 2023 through 2029. With Skin Permeation Testing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Skin Permeation Testing industry.
This Insight Report provides a comprehensive analysis of the global Skin Permeation Testing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Skin Permeation Testing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Skin Permeation Testing market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Skin Permeation Testing and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Skin Permeation Testing.
United States market for Skin Permeation Testing is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Skin Permeation Testing is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Skin Permeation Testing is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Skin Permeation Testing players cover Charles River Laboratories, Xenometrix, Intertek, Eurofins, Tergus Pharma, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Skin Permeation Testing market by product type, application, key players and key regions and countries.
Segmentation by Type:
Human Skin
Animal Skin
Segmentation by Application:
Pharmaceuticals
Agrochemical/Chemical
Cosmetics
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Segmentation by Type:
Human Skin
Animal Skin
Segmentation by Application:
Pharmaceuticals
Agrochemical/Chemical
Cosmetics
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Charles River Laboratories
Xenometrix
Intertek
Eurofins
Tergus Pharma
SGS
Nelson Labs
Revivo BioSystems
Stira Pharmaceuticals
Raptim Research
MedPharm
CPL
Diteba
Topical Products Testing
InVitro Research Solutions
Nuvisan
QPS
CD Formulation
Frontage
Mingjie Pharmaceutical

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 麻豆原创 Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 麻豆原创 Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 麻豆原创 Estimation Caveats
2 Executive Summary
2.1 World 麻豆原创 Overview
2.1.1 Global Skin Permeation Testing 麻豆原创 Size 2019-2030
2.1.2 Skin Permeation Testing 麻豆原创 Size CAGR by Region (2019 VS 2023 VS 2030)
2.1.3 World Current & Future Analysis for Skin Permeation Testing by Country/Region, 2019, 2023 & 2030
2.2 Skin Permeation Testing Segment by Type
2.2.1 Human Skin
2.2.2 Animal Skin
2.3 Skin Permeation Testing 麻豆原创 Size by Type
2.3.1 Skin Permeation Testing 麻豆原创 Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Skin Permeation Testing 麻豆原创 Size 麻豆原创 Share by Type (2019-2024)
2.4 Skin Permeation Testing Segment by Application
2.4.1 Pharmaceuticals
2.4.2 Agrochemical/Chemical
2.4.3 Cosmetics
2.4.4 Others
2.5 Skin Permeation Testing 麻豆原创 Size by Application
2.5.1 Skin Permeation Testing 麻豆原创 Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Skin Permeation Testing 麻豆原创 Size 麻豆原创 Share by Application (2019-2024)
3 Skin Permeation Testing 麻豆原创 Size by Player
3.1 Skin Permeation Testing 麻豆原创 Size 麻豆原创 Share by Player
3.1.1 Global Skin Permeation Testing Revenue by Player (2019-2024)
3.1.2 Global Skin Permeation Testing Revenue 麻豆原创 Share by Player (2019-2024)
3.2 Global Skin Permeation Testing Key Players Head office and Products Offered
3.3 麻豆原创 Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Skin Permeation Testing by Region
4.1 Skin Permeation Testing 麻豆原创 Size by Region (2019-2024)
4.2 Global Skin Permeation Testing Annual Revenue by Country/Region (2019-2024)
4.3 Americas Skin Permeation Testing 麻豆原创 Size Growth (2019-2024)
4.4 APAC Skin Permeation Testing 麻豆原创 Size Growth (2019-2024)
4.5 Europe Skin Permeation Testing 麻豆原创 Size Growth (2019-2024)
4.6 Middle East & Africa Skin Permeation Testing 麻豆原创 Size Growth (2019-2024)
5 Americas
5.1 Americas Skin Permeation Testing 麻豆原创 Size by Country (2019-2024)
5.2 Americas Skin Permeation Testing 麻豆原创 Size by Type (2019-2024)
5.3 Americas Skin Permeation Testing 麻豆原创 Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Skin Permeation Testing 麻豆原创 Size by Region (2019-2024)
6.2 APAC Skin Permeation Testing 麻豆原创 Size by Type (2019-2024)
6.3 APAC Skin Permeation Testing 麻豆原创 Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Skin Permeation Testing 麻豆原创 Size by Country (2019-2024)
7.2 Europe Skin Permeation Testing 麻豆原创 Size by Type (2019-2024)
7.3 Europe Skin Permeation Testing 麻豆原创 Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Skin Permeation Testing by Region (2019-2024)
8.2 Middle East & Africa Skin Permeation Testing 麻豆原创 Size by Type (2019-2024)
8.3 Middle East & Africa Skin Permeation Testing 麻豆原创 Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 麻豆原创 Drivers, Challenges and Trends
9.1 麻豆原创 Drivers & Growth Opportunities
9.2 麻豆原创 Challenges & Risks
9.3 Industry Trends
10 Global Skin Permeation Testing 麻豆原创 Forecast
10.1 Global Skin Permeation Testing Forecast by Region (2025-2030)
10.1.1 Global Skin Permeation Testing Forecast by Region (2025-2030)
10.1.2 Americas Skin Permeation Testing Forecast
10.1.3 APAC Skin Permeation Testing Forecast
10.1.4 Europe Skin Permeation Testing Forecast
10.1.5 Middle East & Africa Skin Permeation Testing Forecast
10.2 Americas Skin Permeation Testing Forecast by Country (2025-2030)
10.2.1 United States 麻豆原创 Skin Permeation Testing Forecast
10.2.2 Canada 麻豆原创 Skin Permeation Testing Forecast
10.2.3 Mexico 麻豆原创 Skin Permeation Testing Forecast
10.2.4 Brazil 麻豆原创 Skin Permeation Testing Forecast
10.3 APAC Skin Permeation Testing Forecast by Region (2025-2030)
10.3.1 China Skin Permeation Testing 麻豆原创 Forecast
10.3.2 Japan 麻豆原创 Skin Permeation Testing Forecast
10.3.3 Korea 麻豆原创 Skin Permeation Testing Forecast
10.3.4 Southeast Asia 麻豆原创 Skin Permeation Testing Forecast
10.3.5 India 麻豆原创 Skin Permeation Testing Forecast
10.3.6 Australia 麻豆原创 Skin Permeation Testing Forecast
10.4 Europe Skin Permeation Testing Forecast by Country (2025-2030)
10.4.1 Germany 麻豆原创 Skin Permeation Testing Forecast
10.4.2 France 麻豆原创 Skin Permeation Testing Forecast
10.4.3 UK 麻豆原创 Skin Permeation Testing Forecast
10.4.4 Italy 麻豆原创 Skin Permeation Testing Forecast
10.4.5 Russia 麻豆原创 Skin Permeation Testing Forecast
10.5 Middle East & Africa Skin Permeation Testing Forecast by Region (2025-2030)
10.5.1 Egypt 麻豆原创 Skin Permeation Testing Forecast
10.5.2 South Africa 麻豆原创 Skin Permeation Testing Forecast
10.5.3 Israel 麻豆原创 Skin Permeation Testing Forecast
10.5.4 Turkey 麻豆原创 Skin Permeation Testing Forecast
10.6 Global Skin Permeation Testing Forecast by Type (2025-2030)
10.7 Global Skin Permeation Testing Forecast by Application (2025-2030)
10.7.1 GCC Countries 麻豆原创 Skin Permeation Testing Forecast
11 Key Players Analysis
11.1 Charles River Laboratories
11.1.1 Charles River Laboratories Company Information
11.1.2 Charles River Laboratories Skin Permeation Testing Product Offered
11.1.3 Charles River Laboratories Skin Permeation Testing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.1.4 Charles River Laboratories Main Business Overview
11.1.5 Charles River Laboratories Latest Developments
11.2 Xenometrix
11.2.1 Xenometrix Company Information
11.2.2 Xenometrix Skin Permeation Testing Product Offered
11.2.3 Xenometrix Skin Permeation Testing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.2.4 Xenometrix Main Business Overview
11.2.5 Xenometrix Latest Developments
11.3 Intertek
11.3.1 Intertek Company Information
11.3.2 Intertek Skin Permeation Testing Product Offered
11.3.3 Intertek Skin Permeation Testing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.3.4 Intertek Main Business Overview
11.3.5 Intertek Latest Developments
11.4 Eurofins
11.4.1 Eurofins Company Information
11.4.2 Eurofins Skin Permeation Testing Product Offered
11.4.3 Eurofins Skin Permeation Testing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.4.4 Eurofins Main Business Overview
11.4.5 Eurofins Latest Developments
11.5 Tergus Pharma
11.5.1 Tergus Pharma Company Information
11.5.2 Tergus Pharma Skin Permeation Testing Product Offered
11.5.3 Tergus Pharma Skin Permeation Testing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.5.4 Tergus Pharma Main Business Overview
11.5.5 Tergus Pharma Latest Developments
11.6 SGS
11.6.1 SGS Company Information
11.6.2 SGS Skin Permeation Testing Product Offered
11.6.3 SGS Skin Permeation Testing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.6.4 SGS Main Business Overview
11.6.5 SGS Latest Developments
11.7 Nelson Labs
11.7.1 Nelson Labs Company Information
11.7.2 Nelson Labs Skin Permeation Testing Product Offered
11.7.3 Nelson Labs Skin Permeation Testing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.7.4 Nelson Labs Main Business Overview
11.7.5 Nelson Labs Latest Developments
11.8 Revivo BioSystems
11.8.1 Revivo BioSystems Company Information
11.8.2 Revivo BioSystems Skin Permeation Testing Product Offered
11.8.3 Revivo BioSystems Skin Permeation Testing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.8.4 Revivo BioSystems Main Business Overview
11.8.5 Revivo BioSystems Latest Developments
11.9 Stira Pharmaceuticals
11.9.1 Stira Pharmaceuticals Company Information
11.9.2 Stira Pharmaceuticals Skin Permeation Testing Product Offered
11.9.3 Stira Pharmaceuticals Skin Permeation Testing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.9.4 Stira Pharmaceuticals Main Business Overview
11.9.5 Stira Pharmaceuticals Latest Developments
11.10 Raptim Research
11.10.1 Raptim Research Company Information
11.10.2 Raptim Research Skin Permeation Testing Product Offered
11.10.3 Raptim Research Skin Permeation Testing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.10.4 Raptim Research Main Business Overview
11.10.5 Raptim Research Latest Developments
11.11 MedPharm
11.11.1 MedPharm Company Information
11.11.2 MedPharm Skin Permeation Testing Product Offered
11.11.3 MedPharm Skin Permeation Testing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.11.4 MedPharm Main Business Overview
11.11.5 MedPharm Latest Developments
11.12 CPL
11.12.1 CPL Company Information
11.12.2 CPL Skin Permeation Testing Product Offered
11.12.3 CPL Skin Permeation Testing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.12.4 CPL Main Business Overview
11.12.5 CPL Latest Developments
11.13 Diteba
11.13.1 Diteba Company Information
11.13.2 Diteba Skin Permeation Testing Product Offered
11.13.3 Diteba Skin Permeation Testing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.13.4 Diteba Main Business Overview
11.13.5 Diteba Latest Developments
11.14 Topical Products Testing
11.14.1 Topical Products Testing Company Information
11.14.2 Topical Products Testing Skin Permeation Testing Product Offered
11.14.3 Topical Products Testing Skin Permeation Testing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.14.4 Topical Products Testing Main Business Overview
11.14.5 Topical Products Testing Latest Developments
11.15 InVitro Research Solutions
11.15.1 InVitro Research Solutions Company Information
11.15.2 InVitro Research Solutions Skin Permeation Testing Product Offered
11.15.3 InVitro Research Solutions Skin Permeation Testing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.15.4 InVitro Research Solutions Main Business Overview
11.15.5 InVitro Research Solutions Latest Developments
11.16 Nuvisan
11.16.1 Nuvisan Company Information
11.16.2 Nuvisan Skin Permeation Testing Product Offered
11.16.3 Nuvisan Skin Permeation Testing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.16.4 Nuvisan Main Business Overview
11.16.5 Nuvisan Latest Developments
11.17 QPS
11.17.1 QPS Company Information
11.17.2 QPS Skin Permeation Testing Product Offered
11.17.3 QPS Skin Permeation Testing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.17.4 QPS Main Business Overview
11.17.5 QPS Latest Developments
11.18 CD Formulation
11.18.1 CD Formulation Company Information
11.18.2 CD Formulation Skin Permeation Testing Product Offered
11.18.3 CD Formulation Skin Permeation Testing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.18.4 CD Formulation Main Business Overview
11.18.5 CD Formulation Latest Developments
11.19 Frontage
11.19.1 Frontage Company Information
11.19.2 Frontage Skin Permeation Testing Product Offered
11.19.3 Frontage Skin Permeation Testing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.19.4 Frontage Main Business Overview
11.19.5 Frontage Latest Developments
11.20 Mingjie Pharmaceutical
11.20.1 Mingjie Pharmaceutical Company Information
11.20.2 Mingjie Pharmaceutical Skin Permeation Testing Product Offered
11.20.3 Mingjie Pharmaceutical Skin Permeation Testing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.20.4 Mingjie Pharmaceutical Main Business Overview
11.20.5 Mingjie Pharmaceutical Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.